Wnt/β-catenin signaling in cancers and targeted therapies

F Yu, C Yu, F Li, Y Zuo, Y Wang, L Yao, C Wu… - … and Targeted Therapy, 2021 - nature.com
Wnt/β-catenin signaling has been broadly implicated in human cancers and experimental
cancer models of animals. Aberrant activation of Wnt/β-catenin signaling is tightly linked with …

WNT as a driver and dependency in cancer

MJ Parsons, T Tammela, LE Dow - Cancer discovery, 2021 - AACR
The WNT signaling pathway is a critical regulator of development and adult tissue
homeostasis and becomes dysregulated in many cancer types. Although hyperactivation of …

Blocking the Wnt/β-catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies

Y Chen, M Chen, K Deng - International journal of …, 2022 - spandidos-publications.com
Colorectal cancer (CRC) is one of the most common malignant tumor types occurring in the
digestive system. The incidence of CRC has exhibits yearly increases and the mortality rate …

Electrochemical meta-C–H sulfonylation of pyridines with nucleophilic sulfinates

S Qin, M Yang, M Xu, ZH Peng, J Cai, S Wang… - Nature …, 2024 - nature.com
Considering the indispensable significance and utilities of meta-substituted pyridines in
medicinal, chemical as well as materials science, a direct meta-selective C–H …

[HTML][HTML] Are Wnt/β-catenin and PI3K/AKT/mTORC1 distinct pathways in colorectal cancer?

A Prossomariti, G Piazzi, C Alquati… - Cellular and molecular …, 2020 - Elsevier
Wnt/β-catenin and phosphatidylinositol-3-kinase/protein kinase B/mammalian target of
rapamycin complex 1 (PI3K/AKT/mTORC1) pathways both are critically involved in …

Distinct colorectal cancer–associated apc mutations dictate response to tankyrase inhibition

EM Schatoff, S Goswami, MP Zafra, M Foronda… - Cancer discovery, 2019 - AACR
The majority of colorectal cancers show hyperactivated WNT signaling due to inactivating
mutations in the adenomatous polyposis coli (APC) tumor suppressor. Genetically restoring …

Small-molecule inhibitors of tankyrases as prospective therapeutics for cancer

M Yu, Y Yang, M Sykes, S Wang - Journal of Medicinal Chemistry, 2022 - ACS Publications
Tankyrases are multifunctional poly (adenosine diphosphate-ribose) polymerases that
regulate diverse biological processes including telomere maintenance and cellular …

[HTML][HTML] Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer

H Zhang, A Steed, M Co, X Chen - Cancer Drug Resistance, 2021 - ncbi.nlm.nih.gov
The cancer stem cell (CSC) state and epithelial-mesenchymal transition (EMT) activation are
tightly interconnected. Cancer cells that acquire the EMT/CSC phenotype are equipped with …

Pyridine-based 1, 2, 4-triazolo-tethered indole conjugates potentially affecting TNKS and PI3K in colorectal cancer

PA Yakkala, SR Panda, VGM Naidu… - ACS Medicinal …, 2023 - ACS Publications
A library of pyridine-based 1, 2, 4-triazolo-tethered indole conjugates were designed,
synthesized, and evaluated for anti-proliferative activity against a panel of six human cancer …

Development of a 1, 2, 4-triazole-based lead tankyrase inhibitor: part II

RGG Leenders, SA Brinch, ST Sowa… - Journal of Medicinal …, 2021 - ACS Publications
Tankyrase 1 and 2 (TNKS1/2) catalyze post-translational modification by poly-ADP-
ribosylation of a plethora of target proteins. In this function, TNKS1/2 also impact the WNT/β …